Skip to main content

Screening for Substance Use and Associated Medical Conditions

  • Chapter
  • First Online:
Treating Adolescent Substance Use

Abstract

Early onset of substance use leads to a higher risk of developing psychosocial problems and a lifelong substance use disorder, which makes screening, prevention, and early intervention instrumental in moderating potential harm. Substance use can be viewed along a continuum from experimentation to problematic substance use and to mild, moderate, and severe substance use disorders. Nonmedical use of prescription medications also operates under a similar continuum and is particularly relevant to the adolescent age group since prescription medications may be more available to young people in some settings than are other substances. This chapter discusses key revisions from the DSM-IV to the DSM-5 and briefly explains how shifts in the diagnostic process impact the implementation of various screening tools. Evidence-based screening instruments are presented and described in detail. Additional health screening recommendations are outlined due to the high-risk behaviors associated with substance use.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Poudel A, Gautam S. Age of onset of substance use and psychosocial problems among individuals with substance use disorders. BMC Psychiatry. 2017;17(1):10.

    Article  Google Scholar 

  2. Bava S, Thayer R, Jacobus J, Ward M, Jernigan TL, Tapert SF. Longitudinal characterization of white matter maturation during adolescence. Brain Res. 2010;1327:38–46.

    Article  CAS  Google Scholar 

  3. American Psychiatric Association. DSM-IV-TR. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC. Substance-related disorders. 2000;191–297.

    Google Scholar 

  4. American Psychiatric Association. DSM-5. Diagnostic and statistical manual of mental disorders 5th ed. Substance-related and addictive disorders. 2013;481–589.

    Google Scholar 

  5. Rahim M, Patton R. The association between shame and substance use in young people: a systematic review. PeerJ. 2015;3:e737.

    Article  Google Scholar 

  6. Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010;21(3):202–7.

    Article  Google Scholar 

  7. Ramirez J, Miranda R. Alcohol craving in adolescents: bridging the laboratory and natural environment. Psychopharmacology. 2014;231(8):1841–51.

    Article  CAS  Google Scholar 

  8. Agrawal A, Heath AC, Lynskey MT. DSM-IV to DSM-5: the impact of proposed revisions on diagnosis of alcohol use disorders. Addiction. 2011;106(11):1935–43.

    Article  Google Scholar 

  9. Hasin DS, Fenton MC, Beseler C, Park JY, Wall MM. Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients. Drug Alcohol Depend. 2012;122(1–2):28–37.

    Article  Google Scholar 

  10. Slade EP, Stuart EA, Salkever DS, Karakus M, Green KM, Ialongo N. Impacts of age of onset of substance use disorders on risk of adult incarceration among disadvantaged urban youth: a propensity score matching approach. Drug Alcohol Depend. 2008;95(1–2):1–13.

    Article  Google Scholar 

  11. Committee on Substance Use and Prevention. Substance use screening, brief intervention, and referral to treatment. Pediatrics. 2016;138(1):e20161210.

    Article  Google Scholar 

  12. Pilowsky DJ, Wu L-T. Screening instruments for substance use and brief interventions targeting adolescents in primary care: a literature review. Addict Behav. 2013;38(5):2146–53.

    Article  Google Scholar 

  13. Committee on Practice and Ambulatory Medicine, Bright Futures Periodicity Schedule Workgroup. 2017 recommendations for preventive pediatric health care. Pediatrics American Academy of Pediatrics. 2017;139(4):e20170254.

    Google Scholar 

  14. Wilson CR, Sherritt L, Gates E, Knight JR. Are clinical impressions of adolescent substance use accurate? Pediatrics. 2004;114(5):e536–40.

    Article  Google Scholar 

  15. Kelly TM, Donovan JE, Chung T, Bukstein OG, Cornelius JR. Brief screens for detecting alcohol use disorder among 18-20 year old young adults in emergency departments: comparing AUDIT-C, CRAFFT, RAPS4-QF, FAST, RUFT-cut, and DSM-IV 2-item scale. Addict Behav. 2009;34(8):668–74.

    Article  Google Scholar 

  16. Knight JR, Sherritt L, Harris SK, Gates EC, Chang G. Validity of brief alcohol screening tests among adolescents: a comparison of the AUDIT, POSIT, CAGE, and CRAFFT. Alcohol Clin Exp Res. 2003;27(1):67–73.

    Article  Google Scholar 

  17. Cook RL, Chung T, Kelly TM, Clark DB. Alcohol screening in young persons attending a sexually transmitted disease clinic. Comparison of AUDIT, CRAFFT, and CAGE instruments. J Gen Intern Med. 2005;20(1):1–6.

    Article  Google Scholar 

  18. Dhalla S, Zumbo BD, Poole G. A review of the psychometric properties of the CRAFFT instrument: 1999–2010. Curr Drug Abuse Rev. 2011;4(1):57–64.

    Article  Google Scholar 

  19. D’Amico EJ, Parast L, Meredith LS, Ewing BA, Shadel WG, Stein BD. Screening in primary care: what is the best way to identify at-risk youth for substance use? Pediatrics. 2016;138(6):e20161717.

    Article  Google Scholar 

  20. Mitchell SG, Kelly SM, Gryczynski J, Myers CP, O’Grady KE, Kirk AS, et al. The CRAFFT cut-points and DSM-5 criteria for alcohol and other drugs: a reevaluation and reexamination. Subst Abus. 2014;35(4):376–80.

    Article  Google Scholar 

  21. Skogen JC, Bøe T, Knudsen AK, Hysing M. Psychometric properties and concurrent validity of the CRAFFT among Norwegian adolescents. Ung@hordaland, a population-based study. Addict Behav. 2013;38(10):2500–5.

    Article  Google Scholar 

  22. Kandemir H, Aydemir Ö, Ekinci S, Selek S, Kandemir SB, Bayazit H. Validity and reliability of the Turkish version of CRAFFT substance abuse screening test among adolescents. Neuropsychiatr Dis Treat. 2015;11:1505–9.

    Article  CAS  Google Scholar 

  23. Wartberg L, Kriston L, Diestelkamp S, Arnaud N, Thomasius R. Psychometric properties of the German version of the CRAFFT. Addict Behav. 2016;59:42–7.

    Article  Google Scholar 

  24. Harris SK, Johnson JK, Sherritt L, Copelas S, Rappo MA, Wilson CR. Putting adolescents at risk: riding with drinking drivers who are adults in the home. J Stud Alcohol Drugs. 2017;78(1):146–51.

    Article  Google Scholar 

  25. U.S. Department of Transportation, National Highway Traffic Safety Administration (NHTSA). Traffic safety facts 2014. https://crashstats.nhtsa.dot.gov/Api/Public/Publication/812261. Accessed 23 July 2018.

  26. Levy S, Weiss R, Sherritt L, Ziemnik R, Spalding A, Van Hook S, et al. An electronic screen for triaging adolescent substance use by risk levels. JAMA Pediatr. 2014;168(9):822–8.

    Article  Google Scholar 

  27. Subramaniam GA, Volkow ND. Substance misuse among adolescents. JAMA Pediatr. 2014;168(9):798.

    Article  Google Scholar 

  28. Knight JR, Harris SK, Sherritt L, Van Hook S, Lawrence N, Brooks T, et al. Adolescents’ preference for substance abuse screening in primary care practice. Subst Abus. 2007;28(4):107–17.

    Article  Google Scholar 

  29. Harris SK, Csémy L, Sherritt L, Starostova O, Van Hook S, Johnson J, et al. Computer-facilitated substance use screening and brief advice for teens in primary care: an international trial. Pediatrics. 2012;129(6):1072–82.

    Article  Google Scholar 

  30. Richardson LP, Rockhill C, Russo JE, Grossman DC, Richards J, McCarty C, et al. Evaluation of the PHQ-2 as a brief screen for detecting major depression among adolescents. Pediatrics. 2010;125(5):e1097–103.

    Article  Google Scholar 

  31. Services USD of H and H. Mandatory guidelines for federal workplace drug testing. Subst Abus Ment Heal Serv Adm. 2004;69(71):1.

    Google Scholar 

  32. Levy S, Siqueira LM. Testing for drugs of abuse in children and adolescents. Pediatrics. 2014;133(6):e1798–807.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patricia C. F. Schram .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Schram, J.W., Schram, P.C.F., Knight, J.R. (2019). Screening for Substance Use and Associated Medical Conditions. In: Welsh, J., Hadland, S. (eds) Treating Adolescent Substance Use. Springer, Cham. https://doi.org/10.1007/978-3-030-01893-1_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-01893-1_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-01892-4

  • Online ISBN: 978-3-030-01893-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics